中国实用医刊
中國實用醫刊
중국실용의간
CENTRAL PLAINS MEDICAL JOURNAL
2010年
23期
5-6
,共2页
秦建武%黑虎%翟翼飞%张松涛
秦建武%黑虎%翟翼飛%張鬆濤
진건무%흑호%적익비%장송도
微创%腔镜辅助%甲状腺切除术
微創%腔鏡輔助%甲狀腺切除術
미창%강경보조%갑상선절제술
Minimally invasive%Video-assisted%Thyroidectomy
目的 探讨微创腔镜辅助下甲状腺切除术与传统开放甲状腺切除术在治疗效果方面的差异.方法 搜集自2008年8月至2010年8月年我院开展的腔镜辅助下甲状腺切除术与同期传统开放甲状腺切除术共计210例,其中腔镜辅助组98例,传统手术组112例.结果 腔镜辅助组切口长度(2.2±0.4) cm、术中出血量(13±7) ml、术后第1天引流量(19±10) ml、手术时间(105±43) min.传统手术组切口长度(5.60±1.0) cm、术中出血量(39±13) ml、术后第1天引流量(51±9) ml、手术时间(60±10) min.两组喉返神经麻痹各1例,无术后出血.结论 对于特定的甲状腺结节患者,腔镜辅助下甲状腺切除术是安全有效的.由于美容效果好、患者术后康复快,是甲状腺外科手术的发展方向.
目的 探討微創腔鏡輔助下甲狀腺切除術與傳統開放甲狀腺切除術在治療效果方麵的差異.方法 搜集自2008年8月至2010年8月年我院開展的腔鏡輔助下甲狀腺切除術與同期傳統開放甲狀腺切除術共計210例,其中腔鏡輔助組98例,傳統手術組112例.結果 腔鏡輔助組切口長度(2.2±0.4) cm、術中齣血量(13±7) ml、術後第1天引流量(19±10) ml、手術時間(105±43) min.傳統手術組切口長度(5.60±1.0) cm、術中齣血量(39±13) ml、術後第1天引流量(51±9) ml、手術時間(60±10) min.兩組喉返神經痳痺各1例,無術後齣血.結論 對于特定的甲狀腺結節患者,腔鏡輔助下甲狀腺切除術是安全有效的.由于美容效果好、患者術後康複快,是甲狀腺外科手術的髮展方嚮.
목적 탐토미창강경보조하갑상선절제술여전통개방갑상선절제술재치료효과방면적차이.방법 수집자2008년8월지2010년8월년아원개전적강경보조하갑상선절제술여동기전통개방갑상선절제술공계210례,기중강경보조조98례,전통수술조112례.결과 강경보조조절구장도(2.2±0.4) cm、술중출혈량(13±7) ml、술후제1천인류량(19±10) ml、수술시간(105±43) min.전통수술조절구장도(5.60±1.0) cm、술중출혈량(39±13) ml、술후제1천인류량(51±9) ml、수술시간(60±10) min.량조후반신경마비각1례,무술후출혈.결론 대우특정적갑상선결절환자,강경보조하갑상선절제술시안전유효적.유우미용효과호、환자술후강복쾌,시갑상선외과수술적발전방향.
Objective To compare the outcome of two groups between minimally invasive video-assisted thyroidectomy(MIVAT) and conventional thyroidectomy. Methods Two hundred and ten patients were enrolled in the study dated from August 2008 to August 2010, 98 patients treated with MIVAT and 112 patients treated with conventional thyroidectomy. Results Patients underwent MIVAT had a mean incision length of (2.2±0.4) cm, compared with (5.6±1.0) cm for conventional thyroidectomy. The mean surgical time for MIVAT was (105±43) minutes, and for conventional thyroidectomy was (60±10) minutes. The mean drainage of the first day after surgery was (19±10) ml in MIVAT group, and the other group was (51±9) ml. The mean intraoperative blood loss was lower in MIVAT group [(13±7) ml] than that in the conventional thyroidectomy group[(39±13) ml]. There was no difference in vocal cord paralysis or postoperative hematoma. Conclusions MIVAT is safe in selected thyroid nodule patients, and has been a new trend for thyroidectomy because of its cosmetic result and quickly recovering.